TriSalus Life Sciences, Inc. (TLSIW) Total liabilities 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) total liabilities at each fiscal year-end, per SEC filings.
$69.2MFY2025 · since FY2022: $34.3M → $69.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $69.2M | +38.8% |
| FY2024 | $49.9M | -3.5% |
| FY2023 | $51.7M | +50.5% |
| FY2022 | $34.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice